Clinical experiences of summary of transurethral resection of prostate for begign prostatic hyperplasia with coronary stent

Objective To summarize the experiences of transurethral resection of prostate(TURP) in the treatment of prostatic hyperplasia patients with coronary stent. Methods The clinical data of 56 BPH patients with coronary stent underwent TURP in our department between 2010 and 2015 were reviewed, aging from 57-86 years and 72 years in average. All patients were treated with TURP operation with fully perioperative preparation including assessment of the risk of surgical anesthesia, blood pressure, cardiac function improvement and suspending the anticoagulation. Results All of the operations were performed successfully without severe complications during the perioperative period. No cardiovascular and cerebrovascular complications and death occurred. The international prostate symptom scores (IPSS) reduced from (26±5) to (12±5), and quality of life scores (QOL) reduced from (5.1±0.8) to (1.9±1.1) postoperatively. Conclusion With fully preoperative preparation, TURP is safe and effective for patients with BPH and coronary sent. Key words: BPH; coronary stent; TURP